Education
About Us
Working with TipRanks
Follow Us
Brian T. Powl Insider Profile
11 Followers
Brian T. Powl, CCO at Fate Therapeutics, holds 183.28K shares in Kura Oncology (Ticker: KURA), holds 41.15K shares in Fate Therapeutics (Ticker: FATE). Most recently, Brian T. Powl Sold ― shares of Kura Oncology on Jan 27, 2026 for an estimated value of $54.26K.
Profitable Transactions
3 out of 5 Profitable Transactions
Average Return
+10.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Brian T. Powl
Brian T. Powl's Trading History
Fate Therapeutics
Jul 06, 2023
CCO
Informative Sell
18.77K
$59.66K
Kura Oncology
Jan 27, 2026
CCO
Informative Sell
54.26K
$1.57M
List of latest transactions for each holding click on a transaction to see Brian T. Powl's performance on stock
You May Also Like
Brian T. Powl insider profile FAQ
What is the percentage of profitable transactions made by Brian T. Powl?
The percentage of profitable transactions made by Brian T. Powl is 60%.
What is the average return per transaction made by Brian T. Powl?
The average return per transaction made by Brian T. Powl is 10.00%.
What stocks does Brian T. Powl hold?
Brian T. Powl holds: FATE, KURA stocks.
What was Brian T. Powl’s latest transaction?
Brian T. Powl latest transaction was an Informative Sell of $54.26K.
What was Brian T. Powl's most profitable transaction?
Brian T. Powl’s most profitable transaction was an Informative Sell of FATE stock on July 6, 2023. The return on the trade was 32.10%.
What is Brian T. Powl's role in Fate Therapeutics?
Brian T. Powl's role in Fate Therapeutics is CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.